[A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands]. 1990

B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
Augenklinik und -poliklinik rechts der Isar der Technischen Universität München.

MK-927 is a new topical carboanhydrase inhibitor with proven ability to lower intraocular pressure in glaucoma patients. Subjective and objective symptoms following topical application of MK-927 were evaluated in a randomized, double-blind, placebo-controlled study in which 24 healthy male volunteers took part. Symptoms were rated according to a visual analog scale by the volunteers and according to a grading scale by the examiner. The study showed good local tolerance of MK-927, comparable to that of Betaxolol.

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008297 Male Males
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
December 1988, Archives of ophthalmology (Chicago, Ill. : 1960),
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
June 1990, Archives of ophthalmology (Chicago, Ill. : 1960),
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
January 1990, Archives of ophthalmology (Chicago, Ill. : 1960),
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
January 1991, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
January 1991, Archives of ophthalmology (Chicago, Ill. : 1960),
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
January 1990, Journal of ocular pharmacology,
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
July 1990, The British journal of ophthalmology,
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
February 1990, Current eye research,
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
January 1990, Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
B Feicht, and H M Hofmann, and E Lippa, and F Brunner-Ferber, and H von Denffer, and H J Merté
January 1991, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!